GreenStar Biosciences Corp.

Recent News

  • GreenStar Biosciences Announces Launch of Science Advisory Board

    Vancouver, British Columbia--(Newsfile Corp. - October 7, 2020) -  GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce the formation and launch of its science advisory board (the "Science Advisory Board") and the appointment of its first distinguished board member, Dr. Mark Geyer, Professor Emeritus at University of California San Diego, who is a recognized pioneer in the psychedelics industry.The Science Advisory Board will serve as a strategic resource for the Company to...

    2020-10-07 8:00 AM ET
  • GreenStar Biosciences Announces Closing of Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - October 5, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it has completed its second and final closing of its previously announced non-brokered private placement of units (the "Units") (the "Offering") for gross proceeds of $866,498.72 (the "Second Tranche Closing"). The Second Tranche Closing consisted of the issuance of an aggregate of 10,831,234 Units at a price of $0.08 per Unit. Each...

    2020-10-05 8:00 AM ET
  • GreenStar Biosciences Announces First Closing of Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - September 21, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it has completed a first closing of its previously announced non-brokered private placement of units (the "Units") of up to Cdn$4,000,000 (the "Offering") for gross proceeds of $831,748.16 (the "First Tranche Closing"). The First Tranche Closing consisted of the issuance of an aggregate of 10,396,852 Units at a price of $0.08 per...

    2020-09-21 8:00 AM ET
  • GreenStar Biosciences Announces New Provisional Patent Application

    Vancouver, British Columbia--(Newsfile Corp. - September 14, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce that its wholly-owned subsidiary, Eleusian Biosciences Corporation ("Eleusian") has added another provisional patent application to the overall existing intellectual property ("IP") portfolio of the Company. This application further expands the portfolio of proprietary psychedelic therapeutics and devices available to GreenStar and strengthens the IP portfolio for treatment of neuropsychiatric disorders with psychedelic compounds. A...

    2020-09-14 8:00 AM ET
  • GreenStar Biosciences Announces Private Placement and Corporate Update

    Vancouver, British Columbia--(Newsfile Corp. - August 17, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF), ("GreenStar" or the "Company"), is pleased to announce that it has engaged Australian boutique brokerage firm, Peak Asset Management ("Peak") to act as non-exclusive financial adviser and raise up to Cdn$4,000,000 (the "Offering") through a private placement of up to 50,000,000 units (the "Units") at a price of $0.08 per Unit. Each Unit will consist of one common share in...

    2020-08-17 9:11 AM ET
  • GreenStar Biosciences Announces Filing of Fourth Provisional Patent Application

    Vancouver, British Columbia--(Newsfile Corp. - August 5, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce that its wholly-owned subsidiary, Eleusian Biosciences Corporation ("Eleusian"), has filed a new provisional patent application, adding to the overall existing intellectual property portfolio of the Company. This application further expands the portfolio of proprietary psychedelic therapeutics available to GreenStar and strengthens the intellectual property ("IP") portfolio for treatment of neuropsychiatric disorders with psychedelic compounds.The new...

    2020-08-05 8:30 AM ET
  • GreenStar Biosciences' Partner Cowlitz Reports Revenues for Q1 2020

    Vancouver, British Columbia--(Newsfile Corp. - July 29, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that its tenant partner Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") has generated over US$6.58 million in gross sales revenues for the three months ended March 31, 2020, resulting in a 24% increase compared to US$ 5.3 million for the first 3 months in 2019, according to data from www.502data.com. GreenStar generates revenues through licensing...

    2020-07-29 8:30 AM ET
  • GreenStar Biosciences Completes Acquisition of 100% of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer

    Vancouver, British Columbia--(Newsfile Corp. - July 27, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce, further to its press release dated July 21, 2020, that it has completed the acquisition of 100% of Toronto, Ontario-based Eleusian Biosciences Corp. ("Eleusian") (the "Transaction") through the issuance of common shares of GreenStar. In addition, the Company is pleased to announce the appointment of Mr. Jonathan Gilbert to the Company's board of directors...

    2020-07-27 9:00 AM ET

Next »